Aharon Gal
Chief Strategy & Growth OfficerNovartis
PharmaceuticalsView Profile →Deputy General Manager · Guangzhou Pharmaceutical Holdings
Peng Wei is Deputy General Manager of Guangzhou Pharmaceutical Holdings and a researcher at Guangzhou National Laboratory. His work includes innovative medicines and advanced therapies.
Last reviewed: Nov 19, 2026
Peng Wei is Deputy General Manager of Guangzhou Pharmaceutical Holdings and a researcher at Guangzhou National Laboratory. His work includes innovative medicines and advanced therapies.
Peng’s research career included work as an assistant researcher and project leader at the Institute of Biophysics of the Chinese Academy of Sciences. He subsequently served as a director and chief scientist at Wuxi Bohuisi Biotechnology.
At Guangzhou National Laboratory, Peng became a researcher and research-group leader. His team’s work has included prevention and treatment approaches for respiratory pathogens. The 2026 Fortune Global 500 Forum’s speaker biography describes research involving small-molecule coronavirus treatments and vaccines targeting respiratory syncytial virus, human metapneumovirus and human parainfluenza virus.
Peng became deputy general manager of Guangzhou Pharmaceutical Holdings in November 2025. His responsibilities connect the group’s innovative-drug and advanced-therapy work with experience in laboratory research and biotechnology commercialization. He has also held chairman and general-manager responsibilities at a Guangzhou biomedical technology-transfer and commercialization company serving universities.
Peng earned a bachelor’s degree from the University of Science and Technology of China and a doctorate from the Chinese Academy of Sciences’ Institute of Biophysics.